These are the five stocks to watch heading into Monday, November 16, 2026. Each received a bullish rating change or new coverage in analyst roundups dated Friday, November 13. Stocks finished lower on Thursday, November 12, after Nvidia CEO Jensen Huang resigned. The S&P 500 fell 26.98 points, or 0.35%, to 7,592.40. The Dow Jones Industrial Average lost 189.40 points, or 0.36%, to 52,297.09, and the Nasdaq Composite slipped 0.39% to 25,366.09. Selling in chip stocks deepened on November 13, as investors weighed October wholesale inflation data and a 10-year Treasury yield near 5.10%. Nvidia reports results November 17, and Palo Alto Networks reports November 18.
The five ideas below span cybersecurity, restaurants, water and cooling services, medical technology, and footwear. Editorial notes only, not investment advice.
Palo Alto Networks (PANW) – KeyBanc Upgrades the Cybersecurity Platform After a Pullback
KeyBanc analyst Eric Heath upgraded Palo Alto Networks from Sector Weight to Overweight on Friday with a $380 price target. He said the stock's roughly 20% pullback over the past month creates an attractive entry point as cybersecurity spending accelerates. Security chiefs at a KeyBanc event suggested budget growth could reach the mid-teens by year-end and exceed 20% in 2027. KeyBanc's reseller survey showed security growth accelerating for a fourth straight quarter. In our view, customers consolidating spending with fewer vendors plays to Palo Alto's broad platform.
Shares traded near $322.51 during Friday's session, roughly flat, giving Palo Alto a market capitalization near $264 billion. The 52-week range runs from $139.57 to $432.33. The trailing price-to-earnings reading exceeds 700 and is not meaningful.
Consensus reads strong buy, with 30 of 35 tracked firms bullish and five neutral. The average price target of $392.71 implies roughly 22% upside, and the KeyBanc target implies about 18%. Wells Fargo's Michael Turrin raised his target to $525 from $475 on October 13.
Risks: Jefferies' Joseph Gallo kept a Buy rating but cut his target to $400 from $450 on November 12. Fiscal first-quarter results due November 18 and competition from AI model vendors remain factors to monitor.
Domino's Pizza (DPZ) – Baird Upgrades the Pizza Chain on a Clearer Sales Path
Baird analyst Chris O'Cull upgraded Domino's Pizza from Neutral to Outperform on Friday and raised his price target to $400 from $320. After meetings with management, he cited a "clearer path to better SSS performance and franchisee profitability." O'Cull said average ticket improved sequentially in the third quarter and should strengthen further in the fourth. In our view, his thesis is notable because it does not require faster transaction growth.
Shares traded near $343.99 during Friday's session, up about 3.23%, giving Domino's a market capitalization near $11.3 billion. The 52-week range runs from $282.00 to $442.35, and the trailing price-to-earnings multiple is 18.93.
Consensus reads buy, with 14 of 23 tracked firms bullish, eight neutral, and one bearish. The average price target of $384.39 implies roughly 12% upside, and the Baird target implies about 16%. BMO's Andrew Strelzik reiterated Outperform with a $390 target.
Risks: Citigroup's Jon Tower cut his target to $308 from $335 on October 14, and Barclays' Jeffrey Bernstein rates the stock Underweight. Baird expects weaker 2026 results to weigh on 2027 store openings, which remains a factor to monitor.
Ecolab (ECL) – Wells Fargo Upgrades the Water and Hygiene Leader on AI Cooling
Wells Fargo analyst Jason Haas upgraded Ecolab from Equal Weight to Overweight on Friday and raised his price target to $380 from $315. He expects Ecolab's pricing surcharge to "remain sticky" into fiscal 2027 and sees strength in life sciences as capacity constraints ease. Haas said the July acquisition of liquid-cooling firm CoolIT Systems expands Ecolab's data center opportunity, including conversions to direct-to-chip cooling. In our view, Ecolab offers AI infrastructure exposure through a defensive, recurring-revenue business.
Shares traded near $309.65 during Friday's session, up about 1.72%, giving Ecolab a market capitalization near $86.8 billion. The 52-week range runs from $243.15 to $318.93, and the trailing price-to-earnings multiple is 42.16.
Consensus reads strong buy, with all 15 tracked firms bullish. The average price target of $335.40 implies roughly 8% upside, and the Wells Fargo target implies about 23%. UBS's Joshua Spector raised his target to $357 from $344 on October 28.
Risks: Shares trade near their 52-week high at a premium multiple. Integration of CoolIT and the durability of surcharge pricing remain factors to monitor.
Haemonetics (HAE) – Jefferies Initiates the Medical Technology Company at Buy
Jefferies analyst Young Li initiated coverage of Haemonetics on Friday with a Buy rating and a $150 price target. He described a diversified medical technology company with a "defensible tech moat" in plasma collection, several recurring growth engines in its MedSurg segment, and a clear path to margin expansion. Jefferies expects strong revenue and earnings growth, with multiple paths to upside in fiscal 2027. In our view, the plasma franchise provides a recurring base while hospital products drive growth.
Shares traded near $122.40 during Friday's session, roughly flat, giving Haemonetics a market capitalization near $5.6 billion. The 52-week range runs from $51.00 to $132.00, and the trailing price-to-earnings multiple is 54.99.
Consensus reads strong buy, with eight of nine tracked firms bullish and one neutral. The average target of $118.22 sits below the share price because older targets remain in the data, so the median of $125.00 and recent targets are better guides. The Jefferies target implies about 23% upside, and Citigroup's Joanne Wuensch raised her target to $149 from $123 on November 6.
Risks: The stock has more than doubled from its 52-week low. Plasma collection volumes and execution on margin goals remain factors to monitor.
Birkenstock (BIRK) – StoneX Initiates the Footwear Brand at Buy
StoneX initiated coverage of Birkenstock with a Buy rating and a $55 price target in a note featured in November 13 analyst roundups. "We are bullish on BIRK, given the brand's increasing relevance, multitude of growth levers, and best-in-class margins that should continue to benefit from greater scale," the firm wrote. In our view, Birkenstock's pricing power stands out in a crowded footwear market.
Shares traded near $36.70 during Friday's session, up about 2.80%, giving Birkenstock a market capitalization near $6.5 billion. The 52-week range runs from $29.93 to $50.73, and the trailing price-to-earnings multiple is 18.07.
Consensus reads strong buy, with 10 of 11 tracked firms bullish and one neutral. The average price target of $56.45 implies roughly 54% upside, though it includes older targets set before the shares declined. The StoneX target implies about 50%.
Risks: Raymond James' Rick Patel kept an Outperform rating but cut his target to $42 from $52 on October 16. Bernstein's Luca Solca rates the stock Market Perform. Consumer demand, tariffs, and currency swings remain factors to monitor.
Found this helpful? Share it with others.